Achieve Life Sciences (ACHV) Net Margin (2010 - 2015)

Achieve Life Sciences' (ACHV) quarterly Net Margin came in at 20.5% in Q4 2015, up 94.74% on a QoQ basis from 389.5% in Q4 2012.

Achieve Life Sciences (ACHV) Net Margin (2010 - 2015) Analysis & Trends

Achieve Life Sciences (ACHV) has 4 years of Net Margin data on file, last reported at 20.5% in Q4 2015.

Quarterly Net Margin changed N/A year-over-year to 20.5% in Q4 2015, while the trailing twelve-month figure through Mar 2016 was 6.26% (changed N/A YoY) and the FY2015 annual result came in at 6.8%, changed N/A from the prior year.
Net Margin climbed to 20.5% in Q4 2015, from 389.5% in the prior quarter.
In the past five years, Net Margin ranged from a high of 346.05% in Q2 2011 to a low of 1600.08% in Q4 2011.
A 3-year average of 284.04% and a median of 253.96% in 2011 frame the typical range for Net Margin.
Annual changes were most pronounced in 2011 — Net Margin sank 148012 bps — and 2012, when it surged 121058 bps.
Tracing ACHV's Net Margin over 3 years: stood at 1600.08% in 2011, then jumped by 76 bps to 389.5% in 2012, then soared by 95 bps to 20.5% in 2015.
The last three Net Margin figures came in at 20.5% (Q4 2015), 389.5% (Q4 2012), and 90.11% (Q3 2012), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Margin (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	32.99%
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	30.23%
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	30.33%
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	13.90%
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	30.98%
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	12.09%
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	12.74%
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-3.12%
10	Achieve Life Sciences	330.88 Mn	330.88 Mn	-	-

Download Data